Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1954 1
1958 1
1960 3
1961 3
1962 1
1963 2
1964 5
1965 4
1967 1
1968 5
1969 3
1970 10
1971 4
1972 3
1973 3
1974 10
1975 10
1976 11
1977 16
1978 25
1979 19
1980 13
1981 21
1982 18
1983 23
1984 18
1985 17
1986 19
1987 18
1988 27
1989 29
1990 30
1991 41
1992 30
1993 36
1994 32
1995 42
1996 53
1997 45
1998 48
1999 42
2000 43
2001 60
2002 75
2003 81
2004 108
2005 114
2006 114
2007 122
2008 132
2009 159
2010 206
2011 221
2012 257
2013 345
2014 394
2015 416
2016 504
2017 484
2018 555
2019 679
2020 740
2021 885
2022 820
2023 859
2024 867
2025 791
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,470 results

Results by year

Filters applied: . Clear all
Page 1
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.
Noor NM, Lee JC, Bond S, Dowling F, Brezina B, Patel KV, Ahmad T, Banim PJ, Berrill JW, Cooney R, De La Revilla Negro J, de Silva S, Din S, Durai D, Gordon JN, Irving PM, Johnson M, Kent AJ, Kok KB, Moran GW, Mowat C, Patel P, Probert CS, Raine T, Saich R, Seward A, Sharpstone D, Smith MA, Subramanian S, Upponi SS, Wiles A, Williams HRT, van den Brink GR, Vermeire S, Jairath V, D'Haens GR, McKinney EF, Lyons PA, Lindsay JO, Kennedy NA, Smith KGC, Parkes M; PROFILE Study Group. Noor NM, et al. Among authors: patel kv. Lancet Gastroenterol Hepatol. 2024 May;9(5):415-427. doi: 10.1016/S2468-1253(24)00034-7. Epub 2024 Feb 22. Lancet Gastroenterol Hepatol. 2024. PMID: 38402895 Free PMC article. Clinical Trial.
British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025.
Moran GW, Gordon M, Sinopolou V, Radford SJ, Darie AM, Vuyyuru SK, Alrubaiy L, Arebi N, Blackwell J, Butler TD, Chew T, Colwill M, Cooney R, De Marco G, Din S, Din S, Feakins R, Gasparetto M, Gordon H, Hansen R, Kok KB, Lamb CA, Limdi J, Liu E, Loughrey MB, McGonagle D, Patel K, Pavlidis P, Selinger C, Shale M, Smith PJ, Subramanian S, Taylor SA, Tun GSZ, Verma AM, Wong NACS; IBD guideline development group. Moran GW, et al. Among authors: patel k. Gut. 2025 Jun 23;74(Suppl 2):s1-s101. doi: 10.1136/gutjnl-2024-334395. Gut. 2025. PMID: 40550582 Free article.
Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN.
Sharman JP, Egyed M, Jurczak W, Skarbnik A, Patel K, Flinn IW, Kamdar M, Munir T, Walewska R, Hughes M, Fogliatto LM, Herishanu Y, Banerji V, Follows G, Walker P, Ghia P, Janssens A, Byrd JC, Ferrant E, Ferrajoli A, Wierda WG, Wachira CW, Suterwala BT, Miranda P, Munugalavadla V, Wun CC, Woyach JA. Sharman JP, et al. Among authors: patel k. Blood. 2025 Sep 11;146(11):1276-1285. doi: 10.1182/blood.2024024476. Blood. 2025. PMID: 40198878 Free article. Clinical Trial.
Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma.
Hansen DK, Peres LC, Dima D, Richards A, Shune L, Afrough A, Midha S, Dhakal B, Kocoglu MH, Atrash S, Ferreri C, Castaneda O, Davis JA, Bhurtel E, McGuirk J, Wagner C, Bansal R, Costello P, Smith K, Lieberman-Cribbin A, De Avila G, Purvey S, Hosoya H, Mikkilineni L, Oswald LB, Kaur G, Pasvolsky O, Gaballa M, Herr MM, Forsberg P, Janakiram M, Htut M, Asoori Maringanti S, Kalariya N, Hashmi H, Reshef R, Sborov DW, Nadeem O, Anwer F, Khouri J, Raza S, Atanackovic D, Alsina M, Freeman CL, Locke FL, Voorhees P, Anderson LD Jr, Richard S, Martin T, Lin Y, Patel KK, Sidana S; US Multiple Myeloma Immunotherapy Consortium. Hansen DK, et al. Among authors: patel kk. J Clin Oncol. 2025 May;43(13):1597-1609. doi: 10.1200/JCO-24-01730. Epub 2025 Feb 18. J Clin Oncol. 2025. PMID: 39965175
Diabetic Neuropathies.
Anandan C, Horak H, Patel K; AANEM. Anandan C, et al. Among authors: patel k. Muscle Nerve. 2025 Sep 12. doi: 10.1002/mus.70015. Online ahead of print. Muscle Nerve. 2025. PMID: 40937532
Editorial Commentary.
Aljabi BN, Patel KR, Rais-Bahrami S. Aljabi BN, et al. Among authors: patel kr. Urol Pract. 2025 May;12(3):354-355. doi: 10.1097/UPJ.0000000000000788. Epub 2025 Mar 24. Urol Pract. 2025. PMID: 40127200 No abstract available.
Surgical endodontics.
Bhanderi S, Patel K. Bhanderi S, et al. Among authors: patel k. Br Dent J. 2025 Apr;238(7):497-507. doi: 10.1038/s41415-025-8406-z. Epub 2025 Apr 11. Br Dent J. 2025. PMID: 40217032 Review.
Standard-of-care idecabtagene vicleucel for relapsed/refractory multiple myeloma.
Sidana S, Ahmed N, Akhtar OS, Brazauskas R, Oloyede T, Bye M, Hansen D, Ferreri C, Freeman CL, Afrough A, Anderson LD Jr, Dhakal B, Dhanda D, Gowda L, Hashmi H, Harrison MJ, Kitali A, Landau H, Mirza AS, Patwardhan P, Qazilbash M, Usmani S, Patel K, Nishihori T, Ganguly S, Pasquini MC. Sidana S, et al. Among authors: patel k. Blood. 2025 Jul 10;146(2):167-177. doi: 10.1182/blood.2024026216. Blood. 2025. PMID: 40198886 Clinical Trial.
Interdigital Macerated Plaques.
Dazé R, Oommen N, Patel K. Dazé R, et al. Among authors: patel k. Am Fam Physician. 2025 Apr;111(4):373-374. Am Fam Physician. 2025. PMID: 40238982 No abstract available.
9,470 results